Bank of Montreal’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-87
Closed -$1K 5257
2021
Q1
$1K Hold
87
﹤0.01% 5025
2020
Q4
$1K Hold
87
﹤0.01% 4896
2020
Q3
$1K Hold
87
﹤0.01% 4731
2020
Q2
$1K Hold
87
﹤0.01% 4591
2020
Q1
$1K Hold
87
﹤0.01% 4017
2019
Q4
$1K Hold
87
﹤0.01% 4830
2019
Q3
$1K Hold
87
﹤0.01% 4691
2019
Q2
$1K Hold
87
﹤0.01% 4814
2019
Q1
$2K Hold
87
﹤0.01% 4174
2018
Q4
$2K Hold
87
﹤0.01% 4450
2018
Q3
$2K Hold
87
﹤0.01% 4427
2018
Q2
$3K Hold
87
﹤0.01% 4286
2018
Q1
$3K Hold
87
﹤0.01% 4010
2017
Q4
$4K Buy
+87
New +$4.35K ﹤0.01% 3975

Other funds holding CYAD

Bank of Montreal's CYAD Position: Q2 2021 in Review

Bank of Montreal sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2021, closing a stake of 87 shares — an estimated $1K sold.

Bank of Montreal first reported a position in CYAD in Q4 2017 and held it in 14 quarters. The position peaked at $4K in Q4 2017. 7 funds tracked by Wall St. Rank hold CYAD as of Q2 2021.

  • Bank of Montreal reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 87 Celyad Oncology SA American Depositary Shares shares in Q2 2021, an estimated $1K.
  • Bank of Montreal first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 14 quarters.
  • Bank of Montreal's Celyad Oncology SA American Depositary Shares position peaked at $4K in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.